Heart rate variability in heart failure

Heart Failure Reviews

Volumn 2, Issue 4, 1998, Pages 235-244

  Sanderson, John E ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Baroreceptor; Heart failure; Heart rate variability

Indexed keywords

AUTONOMIC NERVE; AUTONOMIC NERVOUS SYSTEM; CHOLINERGIC ACTIVITY; HEART FAILURE; HEART RATE VARIABILITY; HUMAN; PRESSORECEPTOR; REVIEW; SYMPATHETIC TONE;

EID: 0031847242     PISSN: 13824147     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009745814816     Document Type: Review

References (58)

1. Eckberg DL, Drabinsky M, Braunwald E. Defective cardiac parasympathetic control in patients with heart disease. N Engl J Med 1971;285:877-883.
2. Porter TR, Eckberg DL, Fritsch JM, Rea RF, Beightol LA, Schmedtje JF Jr, Mohanty PK. Autonomic pathophysiology in heart failure patients. Sympathetic-Cholinergic Interrelations. J Clin Invest. 1990;85:1362-1371.
3. Ferguson DW, Abboud FM, Mark AL. Selective impairment of baroreflex-mediated vasoconstrictor responses in patients with ventricular dysfunction. Circulation 1984;679:451-460.
4. Creager MA, Creager SJ. Arterial baroreflex regulation of blood pressure in patients with congestive heart failure. J Am Coll Cardiol 1994;23:401-405.
5. Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, Simon AB. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984;311:819-823.
6. Benedict CR, Shelton B, Johnstone DE, Francis G, Greenberg B, Konstam M, Probstfield JL, Yusuf S. Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction. Circulation 1996;94:690-697.
7. Hasking GJ, Esler MD, Jennings GL, Burton D, Korner PL Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation 1986;73:615-621.
8. Ewing DJ, Martin CN, Young RJ, Clarke BF. The value of cardiovascular autonomie function tests: 10 years' experience in diabetes. Diabetes Care 1985;8:491-498.
9. Wolfe MM, Varigos GA, Hunt D, Sloman JG. Sinus arrhythmia in acute myocardial infarction. Med J Aust 1978;2:52-53.
10. Akselrod S, Gordon D, Ubel FA, Shannon DC, Barger AC, Cohen RJ. Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat to beat cardiovascular control. Science 1981;213:220-222.
11. Malik M, Farrell T, Cripps T, Camm AJ. Heart rate variability in relation to prognosis after myocardial infarction: selection of optimal processing techniques. Eur Heart J 1989;10:1060-1074.
12. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart Rate Variability. Standards of measurement, physiological interpretation, and clinical use. Circulation 1996;93:1043-1065.
13. Malliani A, Pagani M, Lombardi F, Cerutti S. Cardiovascular neural regulation explored in the frequency domain. Circulation 1991;84:1482-1492.
14. Pagani M, Lombardi F, Guzzetti S, Rimoldi O, Furlan R, Pizzinelli P, Sandrone G, Malfatto G, Dell'Orto S, Piccaluga E, Turiel M, Baselli G, Cerutti S, Malliani A. Power spectral analysis of heart rate and arterial pressure variability as a marker of sympatho-vagal interactions in man and conscious dog. Circ Res 1986;59:178-193.
15. Montano N, Gnecchi-Ruscone T, Porta A, Lombardi F, Pagani M, Malliani A. Power spectrum analysis of heart rate variability to assess the changes in sympatho-vagal balance during graded orthostatic tilt. Circulation 1994;90:1826-1831.
16. Eckberg DL. Sympathovagael balance. A critical appraisal. Circulation 1997;96:3224-3232.
17. Kollai M, Mizsei G. Respiratory sinus arrhythmia is a limited measure of cardiac parasympathetic control in man. J Physiol (Lond) 1990;424:329-342.
18. Saul JP, Berger RD, Albrecht P, Stein SP, Chen MH, Cohen RJ. Transfer function analysis of the circulation: unique in- sights into cardiovascular regulation. Am J Physiol 1991;261:H1231-H1245.
19. Bernardi L, Leuzzi S, Radaelli A, Passino J, Johnston JA, Sleight P. Low-frequency spontaneous fluctuations of R-R interval and blood pressure in conscious humans: a barore-ceptor or central phenomenon? Clin Sci 1994;87:649-654.
20. De Boer RW, Karemaker JW, Strackee J. Hemodynamic fluctuations and baroreflex sensitivity in humans: a beat-to-beat model. Am J Physiol 1987;253:680-689.
21. Madwed JB, Albrecht P, Mark RG, Cohen RJ. Low-frequency oscillations in arterial pressure and heart rate: a simple computer model. Am J Physiol 1989;256:H1573-H1579.
22. Goldberger AL, Rigney DR, Wert BJ. Chaos and fractals in human physiology. Sci Am 1990;46:42-51.
23. Le Pape G, Giacomini H, Swynghedauw B, Mansier P. A statistical analysis of sequences of cardiac interbeat intervals does not support the chaos hypothesis. J Theoret Biol 1997;184:123-31.
24. Sanderson JE, Yeung LYC, Yeung DTK, Kay RLC, Tomlinson B, Critchley JAJH, Woo KS, Bernardi L. Impact of changes in respiratory frequency and posture on power spectral analysis of heart rate and systolic blood pressure variability in normal subjects and patients with heart failure. Clin Sci 1996;90:1-9.
25. Woo MA, Stevenson WG, Moser DK. Comparison of four methods of assessing heart rate variability in patients with heart failure. Am J Crit Care 1996;5:34-41.
26. Saul JP, Arai Y, Berger RD, Lily LS, Wilson S, Colucci WS, Cohen RJ. Assessment of autonomie regulation in chronic congestive heart failure by the heart rate spectral analysis. Am J Cardiol 1988;61:1292-1299.
27. Casolo G, Balli E, Taddei T, Amuhasi J, Gori C. Decreased spontaneous heart rate variability on congestive heart failure. Am J Cardiol 1989;64:1162-1167.
28. Binkley PF, Nunziata E, Haas GJ, Nelson SD, Cody RJ. Parasympathetic withdrawal is an integral component of autonomic imbalance in congestive heart failure: demonstration in human subjects and verification in a paced canine model of ventricular failure. J Am Coll Cardiol 1991;18:464-472.
29. Coumel P, Hermida J-S, Wennerblom B, Leenhardt P, Blanche M, Cauchemez B. Heart rate variability in left ventricular hypertrophy and heart failure, and the effects of beta-blockade. A non-spectral analysis of heart rate variability in the frequency domain and in the time domain. Eur Heart J 1991;12:412-422.
30. Kienzle MG, Ferguson DW, Birkett CL, Myers GA, Berg WJ, Mariano DJ. Clinical hemodynamic and sympathetic neural correlates of heart rate variability in congestive heart failure. Am J Cardiol 1992;69:482-485.
31. Fei L, Keeling PJ, Gill JS, Bashir Y, Statters DJ, Poloniecki J, McKenna WJ, Camm AJ. Heart rate variability and its relation to ventricular arrhythmias in congestive heart failure. Br Heart J 1994;71:322-328.
32. Kingwell BA, Thompson JM, Kaye DM, McPherson GA, Jennings GL, Elser MD. Heart rate spectral analysis, cardiac norepinephrine spillover, and muscle sympathetic nerve activity during human sympathetic nervous activation and failure. Circulation 1994;90:234-240.
33. Mortara A, La Rovere MT, Signorini MG, Pantaleo P, Pinna G, Martinelli L, Ceconi C, Cerutti S, Tavazzi L. Can power spectral analysis of heart rate variability identify a high risk subgroup of congestive heart failure patients with excessive ̈̈sympathetic activation? A pilot study before and after heart transplantation. Br Heart J 1994;71:422-430.
34. Woo MA, Stevenson WG, Moser DK, Middlekauff HR. Complex heart rate variability and serum norepinephrine levels in patients with advanced heart failure. J Am Coll Cardiol 1994;23:565-569.
35. Casolo GC, Stroder P, Sulla A, Chelucci A, Freni A, Zerauschek M. Heart rate variability and functional severity of congestive heart failure secondary to coronary artery disease. Eur Heart J 1995;16:360-367.
36. Guzzetti S, Cogliati C, Turiel M, Crema C, Lombardi F, Malliani A. Sympathetic predominance followed by functional denervation in the progression of chronic heart failure. Eur Heart J 1995;16:1100-1107.
37. Panina G, Khot UN, Nunziata E, Cody RJ, Binkley PF. Assessment of autonomic tone over a 24-hour period in patients with congestive heart failure: relation between mean heart rate and measures of heart rate variability. Am Heart J 1995;129:748-753.
38. Tanabe T, Iwamoto T, Fusegawa Y, Yoshioka K, Shina Y. Alterations of sympathovagal balance in patients with hypertrophic and dilated cardiomyopathies assessed by spectral analysis of RR interval variability. Eur Heart J 1995;16:799-807.
39. Ponikowski P, Chua TP, Amadi AA, Piepoli M, Harrington D, Volterrani M, Colombo R, Mazzuero G, Giordano A, Coats AJ. Detection and significance of a discrete very low frequency rhythm in RR interval variability in chronic congestive heart failure. Am J Cardiol 1996;77: 1320-1326.
40. Butler GC, Ando S, Floras JS. Fractal component of variability of heart rate and systolic blood pressure in congestive heart failure. Clin Sci 1997;92:543-550.
41. Ho KK, Moody GB, Peng CK, Mietus JE, Larson MG, Levy D, Goldberger AL. Predicting survival in heart failure case and control subjects by use of fully automated methods for deriving nonlinear and conventional indices of heart rate dynamics. Circulation 1997;96:842-848.
42. Ponikowski P, Chua TP, Piepoli M, Ondusova D, Webb-Peploe K, Harrington D, Anker SD, Volterrani M, Colombo R, Mazzuero G, Giordano A, Coats AJS. Augmented peripheral chemosensitivity as a potential input to baroreflex impairment and autonomie imbalance in chronic heart failure. Circulation 1997;96:2586-2594.
43. Ponikowski P, Anker SD, Chua TP, Szelemej R, Piepoli M, Adamopoulos S, Webb-Peploe K, Harrington D, Banasiak W, Wrabec K, Coats AJ. Depressed heart rate variability as an independent predictor of death in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1997;79:1645-1650.
44. Szabo BM, van Veldhuisen DJ, van der Veer N, Brouwer J, De Graeff PA, Crijns HJ. Prognostic value of heart rate variability in chronic congestive heart failure secondary to idiopathic or ischemic dilated cardiomyopathy. Am J Cardiol 1997;79:978-980.
45. Van de Borne P, Montano N, Pagani M, Oren R, Somers VK. Absence of low-frequency variability of sympathetic nerve activity in severe heart failure. Circulation 1997;95:1449-1454.
46. Pagani M, Montano N, Porta A, Malliani A, Abboud FM, Cirkett C, Somers VK. Relationship between spectral components of cardiovascular variabilities and direct measures of muscle sympathetic nerve activity in humans. Circulation 1997;95:1441-1448.
47. Malik M, Camm AJ. Components of heart rate variability: what they really mean and what we really measure. Am J Cardiol 1993;72:821-822.
48. Bristow MR, Ginsburg R, Minobe W, Cubicciotti RS, Sageman WS, Lurie K, Billingham ME, Harrison DC, Stimson EB. Decreased catecholamine sensitivity and beta-adrenergic receptor density in failing human hearts. N Engl J Med 1982;307:205-211.
49. Mansier P, Medigue C, Charlotte N, Vermeiren C, Coraboeuf E, Deroubai E, Ratner E, Chevalier B, Clairambault J, Carre F, Dahkli T, Bertin B, Briand P, Strosberg D, Swynghedauw B. Decreased heart rate variability in transgenic mice overexpressing atrial beta 1-adrenoceptors. Am J Physiol 1996;271:1465-1472.
50. Bernardi L, Salvucci F, Suardi R, Solda PL, Calciati A, Perlini S, Falcone C, Ricciardi L. Evidence for an intrinsic mechanism regulating heart rate variability in the transplanted and the intact heart during submaximal dynamic exercise? Cardiovasc Res 1990;24:969-981.
51. Mortara A, La Rovere MT, Pinna GD, Prpa A, Maestri R, Febo O, Pozzoli M, Opasich C, Tavazzi L. Arterial baroreflex modulation of heart rate in chronic heart failure. Clinical and hemodynamic correlates and prognostic implications. Circulation 1997;96:3450-3458.
52. Binkley PF, Haas GJ, Starling RC, Nunziata E, Hatton PA, Leier CV, Cody RJ. Sustained augmentation of parasympathetic tone with angiotensin-converting enzyme inhibition in patients with congestive heart failure. J Am Coll Cardiol 1993;21:655-661.
53. Slatton ML, Irani WN, Hass SA, Marcoux LG, Page RL, Grayburn PA, Eichhorn EJ. Does digoxin provide additional hemodynamic and autonomie benefit at higher doses in patients with mild to moderate heart failure and normal sinus rhythm? J Am Coll Cardiol 1997;29:1206-1213.
54. Casadei B, Conway J, Forfar C, Sleight P. Effect of low doses of scopolamine on RR interval variability, baroreflex sensitivity, and exercise performance in patients with chronic heart failure. Heart 1996;75:274-280.
55. DeGeest H, Levy MN, Zieske H, Lipman RI. Depression of ventricular contractility by stimulation of the vagus nerves. Circ Res 1965;17:222-235.
56. Cleland JGF, Bristow MR, Erdmann E, Remmes WJ, Swedberg K, Waagstein F. Beta-blocking agents in heart failure. Eur Heart J 1996;17:1629-1639.
57. Copie X, Pousset F, Lechat P, Jaillon P, Guize L, Le Heuzey JY. Effects of beta-blockade with bisoprolol on heart rate variability in advanced heart failure: analysis of scatterplots of R-R intervals at selected heart rates. Am Heart J 1996;132:369-375.
58. Sanderson JE, Yeung LY, Chan SK, Yu CM, Kay R, Bernari L. Baroreceptors and beta-blockers in heart failure. J Am Coll Cardiol 1997; 20 (Suppl A):503 A.